AU708825C - Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody - Google Patents

Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody

Info

Publication number
AU708825C
AU708825C AU25701/95A AU2570195A AU708825C AU 708825 C AU708825 C AU 708825C AU 25701/95 A AU25701/95 A AU 25701/95A AU 2570195 A AU2570195 A AU 2570195A AU 708825 C AU708825 C AU 708825C
Authority
AU
Australia
Prior art keywords
lag
production
therapeutic composition
idiotype antibody
soluble polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU25701/95A
Other versions
AU708825B2 (en
AU2570195A (en
Inventor
Florence Faure
Thierry Hercend
Bertrand Huard
Frederic Triebel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Serono SA
Institut Gustave Roussy (IGR)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Merck Serono SA
Institut Gustave Roussy (IGR)
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Serono SA, Institut Gustave Roussy (IGR), Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Merck Serono SA
Priority claimed from PCT/FR1995/000593 external-priority patent/WO1995030750A2/en
Publication of AU2570195A publication Critical patent/AU2570195A/en
Publication of AU708825B2 publication Critical patent/AU708825B2/en
Application granted granted Critical
Publication of AU708825C publication Critical patent/AU708825C/en
Assigned to MERCK SERONO SA, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), INSTITUT GUSTAVE ROUSSY reassignment MERCK SERONO SA Alteration of Name(s) in Register under S187 Assignors: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V., INSTITUT GUSTAVE ROUSSY, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

AU25701/95A 1994-05-06 1995-05-05 Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody Expired AU708825C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9405643 1994-05-06
FR94/05643 1994-05-06
PCT/FR1995/000593 WO1995030750A2 (en) 1994-05-06 1995-05-05 Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU59388/99A Division AU755030B2 (en) 1994-05-06 1999-11-12 LAG-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody

Publications (3)

Publication Number Publication Date
AU2570195A AU2570195A (en) 1995-11-29
AU708825B2 AU708825B2 (en) 1999-08-12
AU708825C true AU708825C (en) 2002-11-28

Family

ID=

Similar Documents

Publication Publication Date Title
HUP9900422A3 (en) Novel protein and methods for the production of the same
AU4855393A (en) Polypeptides of g-coupled receptor proteins, and compositions and methods thereof
PL315914A1 (en) Haemopoesive protein as well as method of and materials for obtaining same
AU3379193A (en) Antigen binding proteins and methods for their production
IL133973A0 (en) IMPROVED ANTI-IgE ANTIBODIES AND METHOD OF IMPROVING POLYPEPTIDES
HUP9801370A3 (en) Stable protein:phospholipid compositions and methods for production thereof
AU7678196A (en) Methods and compositions for the delivery of monomeric proteins
PL331863A1 (en) 7alpha-(xi-aminoalkyl)-estrathienes, method of obtaining them, pharmacautic preparations containing such compounds and their application in production of therapeutic agents
AU5155398A (en) Anti-ccr5 antibodies and methods of use therefor
AU6259998A (en) Isolated p27 protein and methods for its production and use
AU7795298A (en) Complex admixture and method of cement based materials production
AU7266898A (en) Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof
AU4008495A (en) Tcl-1 gene and protein and related methods and compositions
ZA964733B (en) Ob protein compositions and methods
AU5671594A (en) Human tissue factor related dna segments, polypeptides and antibodies
AU5688599A (en) Expression of clostridial toxins and proteins
AU6585498A (en) Novel uncoupling protein and methods of use
AU3916997A (en) Methods for the production of protein particles useful for delivery of pharmacological agents
AU3461095A (en) Compositions and methods for delivery of polypeptides
AU4006695A (en) Calcineurin interacting protein compositions and methods
AU3451397A (en) Modified protein g and fragments thereof
AU3241895A (en) Apoptosis related protein bcl-y, and methods of use thereof
AU1952497A (en) Novel antibody-cytokine fusion protein, and methods of making and using the same
WO2000018909A3 (en) NUCLEIC ACIDS AND PROTEINS FROM $i(CENARCHAEUM SYMBIOSUM)
AU3890689A (en) Human protein c mutants and method for preparing the same